New Key Statistics Module, Z-Score and F-Score
SZSE:300765 Key Ratios
Market Cap ¥ M | 38,696.54 |
Enterprise Value ¥ M | 38,142.20 |
P/E(ttm) | 74.46 |
PE Ratio without NRI | 74.46 |
Forward PE Ratio | 38.59 |
Price/Book | 10.13 |
Price/Sales | 18.93 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 125.26 |
Payout Ratio % | 0.86 |
Revenue (TTM) ¥ M | 2,043.00 |
EPS (TTM) ¥ | 0.37 |
Beneish M-Score | -1.48 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 17.20 |
y-y EBITDA Growth Rate % | 27.40 |
EV-to-EBIT | 62.68 |
EV-to-EBITDA | 62.68 |
PEG | 4.33 |
Shares Outstanding M | 1,404.59 |
Net Margin (%) | 25.11 |
Operating Margin % | 26.96 |
Pre-tax Margin (%) | 30.39 |
Quick Ratio | 2.32 |
Current Ratio | 2.69 |
ROA % (ttm) | 8.82 |
ROE % (ttm) | 11.60 |
ROIC % (ttm) | 17.07 |
Dividend Yield % | 1.16 |
Altman Z-Score | 24.65 |
SZSE:300765 Number of Guru Trades
SZSE:300765 Volume of Guru Trades
Gurus Latest Trades with SZSE:300765
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300765 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CSPC Innovation Pharmaceutical Co Ltd Insider Transactions
No Available Data